KN046 （PD-L1/CTLA4 BsAb）
KN046-208
Phase 2 small_molecule terminated
Quick answer
KN046 （PD-L1/CTLA4 BsAb） for Advanced HCC is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Advanced HCC
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated